Avandia, a Case of Deja Vu all over again
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 26, 2002 FYI Severe Side Effects Reported forClozaril Drug induced inflammation of the heart (myocarditis) isone of several potentially fatal side effects of the so-called ‘atypical’antipsychotic…
FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle Mon, 29 Nov 2004 The Food and Drug Administration is the epicenter of a collision between medical officers in the drug safety office and senior officials in managerial positions whose focus is on facilitating new drug approvals. Officials at the…
Twenty-two years after the US marketing of Prozac, JAMA meta-analysis shows antidepressants to be worthless for most of the people for whom they are prescribed.
Guidant Case May Involve Crime Inquiry Thu, 29 Sep 2005 The New York Times reports that “criminal investigators at the Food and Drug Administration have apparently become involved in the agency’s inquiry into how the Guidant Corporation handled problems with its heart devices, said two people contacted by the investigators."…
Serious Adverse Reaction in Gene Therapy- France & US Halt Trials October 4, 2002 Gene therapy treatment that appears to cure a rare immune disorder often referred to as "bubble boy disease” or SCID, caused by a mutation of the x chromosome in boys, were suspended in France and the…
Studies Link Zyprexa to Diabetes & Deaths_Balt Sun Thu, 20 Mar 2003 Eli Lilly’s best selling drug, olanzapine (Zyprexa), originally approved for schizophrenia, then for bi-polar disorder, is prescribed widely. But the drug has been shown to produce early onset diabetes, severe hyperglycemia–and deaths. Adolescents and young adults appear to…